Patents Assigned to Ascentia Pharma Inc.
  • Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
    Patent number: 7425573
    Abstract: Treating or preventing degeneration or destruction of articular cartilage and/or subchondral bone in the affected joint of a mammal is accomplished by administering a compound of formula (I), wherein the variables have the meanings given in the present description. A preferred compound of formula (I) is formula (II).
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: September 16, 2008
    Assignees: Merckle GmbH, Ascentia Pharma Inc.
    Inventors: Jean-Pierre Pelletier, Johanne Martel-Pelletier